|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
DE122007000007I2
(de)
|
1986-04-09 |
2010-12-30 |
Genzyme Corp |
Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
|
US4992417A
(en)
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogues
|
|
US5082670A
(en)
|
1988-12-15 |
1992-01-21 |
The Regents Of The University Of California |
Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5328470A
(en)
|
1989-03-31 |
1994-07-12 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
US5427940A
(en)
|
1991-06-03 |
1995-06-27 |
Board Of Regents, The University Of Texas System |
Engineered cells producing insulin in response to glucose
|
|
ES2157225T3
(es)
|
1992-10-09 |
2001-08-16 |
Advanced Tissue Sciences Inc |
Celulas hepaticas de reserva.
|
|
US5523226A
(en)
|
1993-05-14 |
1996-06-04 |
Biotechnology Research And Development Corp. |
Transgenic swine compositions and methods
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
JP3802051B2
(ja)
|
1993-08-16 |
2006-07-26 |
リサーチ ディベロップメント ファンデーション |
膵臓島細胞におけるインシュリン表現を刺激する新しいホメオボックス因子
|
|
US5858973A
(en)
|
1994-02-23 |
1999-01-12 |
The General Hospital Corporation |
Transcription factor and uses therefor
|
|
IL114193A
(en)
|
1994-06-20 |
2000-02-29 |
Teva Pharma |
Ophthalmic pharmaceutical compositions based on sodium alginate
|
|
US5849989A
(en)
|
1994-10-07 |
1998-12-15 |
Ontogeny, Inc. |
Insulin promoter factor, and uses related thereto
|
|
JP2000501290A
(ja)
|
1995-11-30 |
2000-02-08 |
リサーチ ディベロップメント ファンデーション |
ソマトスタチン及びインシュリン生成を刺激する化合物のスクリーニング・アッセイ
|
|
IL118376A0
(en)
|
1996-05-22 |
1996-09-12 |
Univ Ben Gurion |
Polysaccharide sponges for cell culture and transplantation
|
|
JP2000513227A
(ja)
|
1996-06-24 |
2000-10-10 |
ビーボウアールエックス ファーマスーティカルズ，インコーポレイテッド |
インスリン分泌細胞の単離および増殖方法
|
|
EP0996736A1
(en)
|
1997-08-11 |
2000-05-03 |
Chiron Corporation |
Methods for genetically modifying t cells
|
|
CA2221195A1
(en)
|
1997-11-14 |
1999-05-14 |
Chantal E. Holy |
Biodegradable polymer matrix
|
|
US6143293A
(en)
|
1998-03-26 |
2000-11-07 |
Carnegie Mellon |
Assembled scaffolds for three dimensional cell culturing and tissue generation
|
|
IL124957A0
(en)
|
1998-06-16 |
1999-01-26 |
Univ Ben Gurion |
Active ingredient delivery systems and devices based on porous matrices
|
|
US6242666B1
(en)
|
1998-12-16 |
2001-06-05 |
The Scripps Research Institute |
Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
|
|
US8778899B2
(en)
|
1999-06-01 |
2014-07-15 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
|
US6774120B1
(en)
|
1999-06-01 |
2004-08-10 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
|
US6716824B1
(en)
|
1999-10-22 |
2004-04-06 |
F. Charles Brunicardi |
Treatment of pancreatic adenocarcinoma by cytotoxic gene therapy
|
|
US6759039B2
(en)
|
2000-06-30 |
2004-07-06 |
Amcyte, Inc. |
Culturing pancreatic stem cells having a specified, intermediate stage of development
|
|
US7214371B1
(en)
|
2000-09-01 |
2007-05-08 |
Ben-Gurion University Of The Negev Research & Development Authority |
Tissue engineered biografts for repair of damaged myocardium
|
|
WO2003020894A2
(en)
|
2001-08-31 |
2003-03-13 |
Joslin Diabetes Center, Inc. |
Insulin related transcription factor and uses thereof
|
|
CA2463914A1
(en)
|
2001-10-18 |
2003-04-24 |
Ixion Biotechnology, Inc. |
Conversion of liver stem and progenitor cells to pancreatic functional cells
|
|
US7722894B2
(en)
|
2001-10-22 |
2010-05-25 |
Massachusetts Institute Of Technology |
Biodegradable polymer
|
|
IL162131A0
(en)
|
2001-12-07 |
2005-11-20 |
Geron Corp |
Islet cells from human embryonic stem cells
|
|
AU2003217658A1
(en)
*
|
2002-02-22 |
2003-09-09 |
University Of Florida |
Cellular trans-differentiation
|
|
GB0206357D0
(en)
|
2002-03-18 |
2002-05-01 |
Univ Bath |
Cells
|
|
JP4136434B2
(ja)
|
2002-04-17 |
2008-08-20 |
進 清野 |
インスリン産生細胞の誘導
|
|
WO2003102171A1
(en)
|
2002-05-28 |
2003-12-11 |
Becton, Dickinson And Company |
Expansion and transdifferentiation of human acinar cells
|
|
KR101180896B1
(ko)
|
2003-05-05 |
2012-09-07 |
벤-구리온 유니버시티 오브 더 네게브 리서치 앤드 디벨럽먼트 어쏘러티 |
주사용 가교결합된 폴리머 제제 및 그의 용도
|
|
AU2004236573B2
(en)
|
2003-05-12 |
2009-10-22 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
|
WO2005005607A2
(en)
|
2003-06-30 |
2005-01-20 |
Lifescan, Inc. |
Seeding pancreatic cells on porous matrices
|
|
CA2536067A1
(en)
|
2003-08-27 |
2005-03-10 |
Stemcells California, Inc. |
Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
|
|
CA2548464C
(en)
|
2003-12-09 |
2013-02-12 |
Ben-Gurion University Of The Negev Research And Development Authority |
Pulse-medium perfusion bioreactor with improved mass transport for multiple 3-d cell constructs
|
|
EP1784481A1
(en)
|
2004-08-25 |
2007-05-16 |
Technion Research And Development Foundation, Ltd. |
Methods of generating embryoid bodies using three dimensional scaffolds
|
|
WO2006092799A1
(en)
|
2005-03-02 |
2006-09-08 |
Polyrizon Ltd. |
Method for removal of toxins from mucosal membranes
|
|
EP1856246B1
(en)
|
2005-03-07 |
2015-07-15 |
Technion Research & Development Foundation Limited |
Natural tissue-derived decellularized matrix and methods of generating and using same
|
|
US7517856B2
(en)
|
2005-10-11 |
2009-04-14 |
Ben-Gurion University Of The Negev Research And Development Authority |
Bioconjugates comprising sulfated polysaccharides and their uses
|
|
EP2054079A4
(en)
*
|
2006-07-19 |
2009-12-23 |
Univ Florida |
COMPOSITIONS FOR CELL REPROGRAMMING AND USES THEREOF
|
|
WO2008075339A2
(en)
|
2006-12-18 |
2008-06-26 |
Ben Gurion University Of The Negev |
Scaffolding for tissue regeneration or repair
|
|
WO2009007979A2
(en)
|
2007-07-11 |
2009-01-15 |
Technion Research & Development Foundation Ltd. |
Encapsulated mesenchymal stem cells and uses thereof
|
|
IL187707A0
(en)
|
2007-11-27 |
2008-11-03 |
Univ Ben Gurion |
Alginate scaffold in hepatectomy
|
|
WO2009126927A2
(en)
*
|
2008-04-11 |
2009-10-15 |
Joslin Diabetes Center, Inc. |
Methods of generating insulin-producing cells
|
|
WO2010022395A2
(en)
*
|
2008-08-22 |
2010-02-25 |
President And Fellows Of Harvard College |
Methods of reprogramming cells
|
|
CN102858380B
(zh)
|
2009-08-02 |
2016-03-23 |
学校法人东京女子医科大学 |
胰岛细胞片、制造方法及其利用方法
|
|
KR101874463B1
(ko)
*
|
2009-10-31 |
2018-08-02 |
뉴 월드 레보러토리즈 인코포레이티드. |
세포의 재프로그램화 방법 및 이의 용도
|
|
JP2011223993A
(ja)
|
2010-03-30 |
2011-11-10 |
Kumamoto Univ |
幹細胞の分化誘導方法
|
|
WO2011159726A2
(en)
|
2010-06-14 |
2011-12-22 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
|
EP2741753A2
(en)
|
2011-08-09 |
2014-06-18 |
Yeda Research and Development Co. Ltd. |
Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
|
|
EP2816964B1
(en)
|
2012-02-21 |
2023-12-27 |
Ben-Gurion University of The Negev Research and Development Authority |
Hydrogel system comprising spatially separated bioactive polypeptides
|
|
US9993497B2
(en)
|
2012-12-30 |
2018-06-12 |
Hadasit Medical Research Services And Development Ltd. |
Use of alginate compositions in preventing or reducing liver damage caused by a hepatotoxic agent
|
|
JP6490669B2
(ja)
|
2013-05-08 |
2019-03-27 |
インリージェン |
単離腎細胞を含有するオルガノイド及びその使用
|
|
JP6650393B2
(ja)
*
|
2013-06-13 |
2020-02-19 |
オージェネシス リミテッド |
細胞の集団、分化転換の方法及びその使用方法
|
|
EP3107549B1
(en)
|
2014-02-20 |
2020-07-01 |
B.G. Negev Technologies and Applications Ltd. |
Anionic polyplexes for use in the delivery of nucleic acids
|
|
EP3149067B1
(en)
|
2014-05-30 |
2021-03-17 |
The Secant Group, LLC |
Water-mediated preparations of polymeric materials
|
|
EP3149026B1
(en)
|
2014-06-02 |
2025-03-05 |
B.G. Negev Technologies and Applications Ltd. |
Site-selective modification of polysaccharides and applications thereof
|
|
MA41296A
(fr)
|
2014-12-30 |
2017-11-07 |
Orgenesis Ltd |
Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
|
|
WO2017118979A1
(en)
|
2016-01-07 |
2017-07-13 |
B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University |
Compositions and methods for generating immunotolerant responses
|
|
WO2017175229A1
(en)
|
2016-04-07 |
2017-10-12 |
B.G. Negev Technologies And Applications Ltd. |
Polysaccharide compositions and uses thereof
|
|
US20170290954A1
(en)
|
2016-04-07 |
2017-10-12 |
B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University |
Compositions and methods for treating spinal cord injury
|
|
EP3635106A4
(en)
|
2017-05-08 |
2021-01-06 |
Orgenesis Ltd. |
POPULATIONS OF TRANSDIFFERENTIATED CELLS AND THEIR METHODS OF USE
|